According to the findings that conversely to mutp53, wtp53 may inhibit the activation of several pro-survival pathways and counteract inflammatory cytokine release, in this study, we found that in wtp53-carrying cancer cells, the activation of p21 following p53-R273H transfection counteracted cell proliferation, ROS production and cytokine release. Here, TP53 is linked to cancer.